Date published: 2025-10-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pramipexole dihydrochloride monohydrate (CAS 191217-81-9)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride hydrate
Application:
Pramipexole dihydrochloride monohydrate is a non-ergoline dopamine agonist
CAS Number:
191217-81-9
Purity:
≥99%
Molecular Weight:
302.268
Molecular Formula:
C10H17N3S•2HCl•H2O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Pramipexole dihydrochloride monohydrate is an activator of D2DR, D3DR and D4DR.


Pramipexole dihydrochloride monohydrate (CAS 191217-81-9) References

  1. Validated chiral liquid chromatographic method for the enantiomeric separation of Pramipexole dihydrochloride monohydrate.  |  Pathare, DB., et al. 2006. J Pharm Biomed Anal. 41: 1152-6. PMID: 16580170
  2. Analysis of the anti-Parkinson drug pramipexole in human urine by capillary electrophoresis with laser-induced fluorescence detection.  |  Musenga, A., et al. 2008. Anal Chim Acta. 626: 89-96. PMID: 18761125
  3. Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.  |  Soto, E., et al. 2010. Pharm Res. 27: 340-9. PMID: 20039105
  4. Stability studies and structural characterization of pramipexole.  |  Łaszcz, M., et al. 2010. J Pharm Biomed Anal. 53: 1033-6. PMID: 20655682
  5. Development and validation of a chiral capillary electrophoresis method for assay and enantiomeric purity control of pramipexole.  |  Deng, X., et al. 2011. J Sep Sci. 34: 3070-6. PMID: 21905218
  6. The benefits of pramipexole selection in the treatment of Parkinson's disease.  |  Silindir, M. and Ozer, AY. 2014. Neurol Sci. 35: 1505-11. PMID: 25038745
  7. The cooperative effect of reduced graphene oxide and Triton X-114 on the electromembrane microextraction efficiency of Pramipexole as a model analyte in urine samples.  |  Fashi, A., et al. 2017. Talanta. 162: 210-217. PMID: 27837820
  8. A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole.  |  Putri, RS., et al. 2016. Sci Pharm. 84: 715-723. PMID: 27869754
  9. Novel contribution to the simultaneous monitoring of pramipexole dihydrochloride monohydrate and levodopa as co-administered drugs in human plasma utilizing UPLC-MS/MS.  |  Mohamed, D., et al. 2018. Eur J Mass Spectrom (Chichester). 24: 397-407. PMID: 30012017
  10. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.  |  Gültekin, HE., et al. 2019. Pharm Res. 36: 128. PMID: 31250313
  11. A Rare Case of Green Gelatinous Mass Formation on a Deep Brain Stimulation Implantable Pulse Generator.  |  Poortvliet, PC., et al. 2021. J Mov Disord. 14: 81-83. PMID: 32854483
  12. Applications of Potentiometric Sensors for the Determination of Drug Molecules in Biological Samples.  |  Özbek, O., et al. 2022. Crit Rev Anal Chem. 52: 768-779. PMID: 32991203
  13. Age-Stratified Risk of Dementia in Parkinson's Disease: A Nationwide, Population-Based, Retrospective Cohort Study in Taiwan.  |  Chang, TY., et al. 2021. Front Neurol. 12: 748096. PMID: 35002917
  14. Precise Dosing of Pramipexole for Low-Dosed Filament Production by Hot Melt Extrusion Applying Various Feeding Methods.  |  Chamberlain, R., et al. 2022. Pharmaceutics. 14: PMID: 35057112

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Pramipexole dihydrochloride monohydrate, 10 mg

sc-280015
10 mg
$120.00